SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-001658
Filing Date
2021-02-16
Accepted
2021-02-16 07:30:48
Documents
2
Period of Report
2021-02-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K edsa_8k.htm 8-K 31110
2 PRESS RELEASE ISSUED BY EDESA BIOTECH, INC. DATED FEBRUARY 16, 2021. edsa_ex991.htm EX-99.1 141103
  Complete submission text file 0001654954-21-001658.txt   173395
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 21632443
SIC: 2834 Pharmaceutical Preparations